Partnerships

An artificial pancreas originally developed at the University of Virginia Center for Diabetes Technology safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found.

The Commonwealth of Virginia will receive 60,000 nasopharyngeal swabs weekly to support high-priority COVID-19 testing across the state, thanks to a collaboration led by University of Virginia faculty to design this key testing supply.

To help keep Charlottesville and the surrounding area safe, UVA Health is teaming up with the Virginia Department of Health, Thomas Jefferson Health District and community partners to offer four free COVID-19 testing events each week.

A UVA Health-developed artificial pancreas system is among the nominees for 2019’s best biomedical research and is fighting to win…

The U.S. Food and Drug Administration has approved an artificial pancreas system – based on technology from the University of…

University of Virginia (UVA) Center for Diabetes Technology and Novo Nordisk today announced that they have entered into a five-year research collaboration where UVA and Novo Nordisk will work together on the development of virtual environments focused on modelling of patients with type 2 diabetes.

Only 8% of Americans survive cardiac arrest outside a hospital, but that percentage could increase significantly if bystanders recognize cardiac…

UVA Health has established a 16-person Advisory Council that will inform and advise UVA Health leaders as they consider additional improvements to billing and collection policies and practices to better meet the needs of patients.

Only 20% of an individual’s health status is related to clinical health care. The other 80% are shaped by socioeconomic factors, their physical environment, and their health behaviors. Having access to healthy foods, safe and stable housing, reliable transportation and a well-paying job leads to increased well-being. To better connect patients with community resources that can meet these needs, UVA Health purchased a technology-based referral network, PIECES Iris™.

A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.